1 %The Pfcrt haplotype CVIET decreased to 1% in 2017 in Kenya.
Kenyapaludismeobserved 2017published 2025Malaria journalPubMeddocument of 14 observations
Gold tier: mechanically validated evidence, with its primary source.
1,713 evidence items · page 9 / 69
1 %The Pfcrt haplotype CVIET decreased to 1% in 2017 in Kenya.
Kenyapaludismeobserved 2017published 2025Malaria journalPubMeddocument of 14 observations
Mild-to-moderate hypercalcemia was common at admission, particularly among children with severe anemia.
Kenyapaludismepublished 2005Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 4 observationsDOI 10.1086/426022
70 per_100Sub-counties in the north of the lake-endemic region exhibited the highest population-weighted malaria test positivity rates, with exceedance probability > 70% with 90% certainty.
Kenyapaludismeobserved 2018-2019published 2021Malaria journaleurope_pmcdocument of 4 observations
25 %The median Plasmodium falciparum PCR-positive prevalence (PCRpfPR) among children aged 7 months to 10 years was 25% in the intervention arm after 5 months.
Kenyapaludismepublished 2021The American journal of tropical medicine and hygienePubMeddocument of 10 observations
15 %In the moderate and high malaria risk strata, intermittent preventive therapies for school children in addition to existing vector control was predicted to reduce incidence by an additional 15%.
Kenyapaludismepublished 2022Malaria journaleurope_pmcdocument of 4 observationsDOI 10.1186/s12936-022-04099-5
0.9 %The A675V mutation was absent in 2019 and increased from 0.9% in 2022 to 5% in 2023.
Kenyapaludismeobserved 2022published 2025Scientific reportsPubMeddocument of 6 observations
39 %Plasmodium falciparum parasite prevalence by qPCR rose to 39% among 90 adults on day 84.
Kenyapaludismepublished 2020Comparing drug regimens for clearance of malaria parasites in asymptomatic adults using PCeurope_pmcdocument of 4 observations
24 %Almost a quarter of patients (24%) admitted with a malaria diagnosis had a reported comorbidity.
Kenyapaludismeobserved June 2016 to May 2017published 2021Malaria journalPubMeddocument of 11 observations
4.7 %In the PERCH study, the prevalence of malaria parasitaemia was 4.7% among WHO pneumonia cases.
Kenyapaludismepublished 2025International journal of epidemiologyeurope_pmcdocument of 8 observations
1.2 per_1000The mean incidence of Plasmodium falciparum in 2009 was 1.2 cases per 1000 population.
Kenyapaludismeobserved 2009published 2014PloS oneeurope_pmcdocument of 7 observations
0 prevalence_differenceThe adjusted site-specific prevalence difference for spontaneous abortion among Kenyan women with first-trimester malaria was 0.00.
Kenyapaludisme · spontaneous abortionpublished 2024PloS onePubMeddocument of 14 observations
6 %Babies born to primigravidae who received Maloprim had 6% low birth weight compared to 22% in those who received placebo.
Kenyapaludismepublished 1989Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 7 observations
92.2 %The positive predictive value of microscopy for detecting P. falciparum parasitaemia was 92.2% in asymptomatic children aged 7–14 years in western Kenya.
Kenyapaludismepublished 2022Malaria journalPubMeddocument of 6 observations
5.6 %Sporozoite prevalence was 5.6% in Anopheles funestus.
Kenyapaludismeobserved 2020published 2022Parasites & vectorsPubMeddocument of 6 observations
178,600,000 inhabitantsIn 2000, 178.6 million (28.1%) people lived in areas of mesoendemic transmission (>10% to 50% PfPR2-10) in Africa.
Kenyapaludismeobserved 2000published 2014Lancet (London, England)europe_pmcdocument of 4 observations
There was a significant difference in probability of non-infection during malaria episodes in the study sites, with Kombewa having the least median time of non-infection during malaria episodes.
Kenyapaludismepublished 2022Parasites & vectorsPubMeddocument of 7 observations
100 %Wild Anopheles gambiae sensu lato (s.l.) and Anopheles funestus s.l. showed 100% susceptibility to broflanilide.
Kenyapaludismepublished 2025Malaria journalPubMeddocument of 6 observations
In the field study, immature and adult Anopheles mosquito populations were significantly lower in the intervention village compared to the control village during the larviciding period.
KenyaAnopheles · paludismeobserved larviciding periodpublished 2020Malaria journalPubMeddocument of 4 observations
There were no re-infections observed during the stated 28-day follow-up period.
Kenyapaludismeobserved 2015published 2021Epidemiology and infectionPubMeddocument of 5 observations
7.8 %7.8% (53/683) of tested mosquito abdomens were positive for Plasmodium falciparum.
Kenyapaludismepublished 2024Parasites & vectorsPubMeddocument of 5 observations
3,000,000,000 peopleMore than 3 billion people were at risk of malaria in 2005.
Kenyapaludismeobserved 2005published 2006Advances in parasitologyeurope_pmcDOI 10.1016/s0065-308x(05)62005-2
49 %Among children aged 3-59 months who received malaria chemoprophylaxis from a village health worker in addition to treatment, there was a 49% reduction in mortality.
Kenyapaludismepublished 1990Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 2 observations
31 %Malaria test positivity rate (TPR) among febrile admissions aged 1 month to 14 years at Tororo district hospital was 31% during the final period of Actellic IRS and LLIN (June 2016–December 2019).
Kenyapaludismeobserved June 2016–December 2019published 2020Malaria journaleurope_pmcdocument of 4 observationsDOI 10.1186/s12936-020-03490-4
100,000,000 inhabitants0.10 billion people at risk of Plasmodium vivax transmission were located in the Africa+ region in 2009, representing 3.5% of the total population at risk.
Kenyapaludismeobserved 2009published 2010PLoS neglected tropical diseaseseurope_pmcdocument of 5 observationsDOI 10.1371/journal.pntd.0000774
1,526 participantsA total of 1526 and 1546 participants from two consecutive, 12-month cohorts were assessed for first-time malaria infection.
Kenyapaludismepublished 2025Lancet (London, England)PubMeddocument of 4 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.